Standard Biotools Inc.
LAB· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Revenue | $29.64M | $18.29M | $12.78M | $10.60M |
| Net Income | -$13.79M | -$4.29M | -$4.15M | -$4.49M |
| EPS Diluted | -$0.49 |
Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR
| -$0.17 |
| -$0.18 |
| -$0.22 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.